The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins, including (i.e., IL-17, IL-1), anti-TNF, JAKi, and anti-complement factor. The …
Category Archives: Healthcare Trends
Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2033
The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as preventative medicine becomes more widely used and …
Takotsubo Syndrome Therapeutics Market is projected to exhibit a compound annual growth rate (CAGR) of 6.1% from 2023 to 2033
The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as valvular heart …
Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period 2017-2022. The increasing prevalence of Congenital Hyperinsulinism disease is …
Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033
According to a recent report published by Future Market Insights, demand for cannabis use disorder treatment is poised to grow at a CAGR of 4.9% from 2023 to 2033. By the end of the aforementioned period of assessment, a valuation worth US$ 2.66 billion is anticipated. Today’s global cannabis market is measured in billions of dollars, which …
Continue reading “Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033”
Chloangiocarcinoma (CCA) Therapeutics Market is expected to garner a market value of US$ 800 Million in 2023
The global Chloangiocarcinoma Therapeutics Market is anticipated to reach a market value of US$ 800 Million in 2023 and US$ 975.20 Million by registering a CAGR of 2% from 2023 to 2033. Inflammatory bowel disease, exposure to specific toxins, and changes in bile duct anatomy are all factors contributing to the growth of the cholangiocarcinoma …
Intratumoral Cancer Therapies Market is expected to accumulate a market value of US$ 552.36 Billion – FMI
A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for cancer …
Tendonitis Treatment Market is expected to grow at a CAGR of 4.3% during 2022 to 2032
A recent analytical analysis by Future Market Insights estimates that the global Tendonitis Treatment Market will generate revenues of US$ 193.7 billion in 2021. With a CAGR of 4.1%, the market growth between 2022 and 2032 is projected to be much higher than the historical average. Tendonitis therapy is expected to grow at a CAGR of 4.3% …
Postoperative Pain Market is projected to surpass a valuation of US$ 63.8 billion by 2033
The global postoperative pain market is expected to be valued at US$ 38.43 billion in 2023, rising to US$ 63.8 billion by 2033. During the forecast period, the use of postoperative pain medications is expected to increase at a CAGR of 5.2%. Crucial information and forecast statistics covered in the Postoperative Pain market report will arm both …
Chronic Pain Market is expected predicted to develop from US$ 73.14 billion in 2023
The chronic pain market is anticipated to grow from US$ 73.14 Billion in 2023 to US$ 142.53 Billion by 2033, rising at a CAGR of 6.9% during the forecast period. Globally, there were more than 187 Million cases of chronic pain in 2020, and from 2023 to 2033, it is predicted that this number would increase dramatically. An ageing population, an increase in the prevalence of chronic health …